カテゴリー： GlobalInfoResearch, 世界

脂質異常症治療薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global Dyslipidemia Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9101945）・商品コード：GIR9101945
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年9月16日（※2024年版があります。お問い合わせください）
・ページ数：123
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、脂質異常症治療薬の世界市場について調べ、まとめました。種類別セグメントは、スタチン、非スタチン、併用薬等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。脂質異常症治療薬の世界市場概観、企業動向、企業別脂質異常症治療薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・脂質異常症治療薬の市場概観
・脂質異常症治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・脂質異常症治療薬の企業別販売動向、市場シェア、市場集中度、競争動向
・脂質異常症治療薬の世界市場規模
・脂質異常症治療薬の北米市場分析（アメリカ、カナダ、メキシコ等）
・脂質異常症治療薬のアメリカ市場規模推移
・脂質異常症治療薬のカナダ市場規模推移
・脂質異常症治療薬のメキシコ市場規模推移
・脂質異常症治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・脂質異常症治療薬のドイツ市場規模推移
・脂質異常症治療薬のイギリス市場規模推移
・脂質異常症治療薬のロシア市場規模推移
・脂質異常症治療薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・脂質異常症治療薬の日本市場規模推移
・脂質異常症治療薬の中国市場規模推移
・脂質異常症治療薬の韓国市場規模推移
・脂質異常症治療薬のインド市場規模推移
・脂質異常症治療薬の東南アジア市場規模推移
・脂質異常症治療薬の南米市場分析（ブラジル、アルゼンチン等）
・脂質異常症治療薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・脂質異常症治療薬の種類別分析/販売量、売上、市場シェア（スタチン、非スタチン、併用薬）
・脂質異常症治療薬の用途別分析/市場規模（病院薬局、小売薬局、オンライン薬局）
・脂質異常症治療薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・脂質異常症治療薬の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Dyslipidemia is an abnormal amount of lipids (e.g. triglycerides, cholesterol and/or fat phospholipids) in the blood. In this report, Dyslipidemia Therapeutics are divided into statins, non-statins and combinations drugs.

Scope of the Report:
The global Dyslipidemia Therapeutics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Dyslipidemia Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Dyslipidemia Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Dyslipidemia Therapeutics market by product type and applications/end industries.

Market Segment by Companies, this report covers
Pfizer
Sanofi
Amgen
Merck
Novartis
Abbott Laboratories
AstraZeneca
Mylan
Kowa Pharmaceuticals
Novelion Therapeutics

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Statins
Non-Statins
Combinations Drugs

Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

【レポートの目次】

Table of Contents

1 Dyslipidemia Therapeutics Market Overview
1.1 Product Overview and Scope of Dyslipidemia Therapeutics
1.2 Classification of Dyslipidemia Therapeutics by Types
1.2.1 Global Dyslipidemia Therapeutics Revenue Comparison by Types (2019-2024)
1.2.2 Global Dyslipidemia Therapeutics Revenue Market Share by Types in 2018
1.2.3 Statins
1.2.4 Non-Statins
1.2.5 Combinations Drugs
1.3 Global Dyslipidemia Therapeutics Market by Application
1.3.1 Global Dyslipidemia Therapeutics Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Dyslipidemia Therapeutics Market by Regions
1.4.1 Global Dyslipidemia Therapeutics Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Dyslipidemia Therapeutics Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Dyslipidemia Therapeutics Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Dyslipidemia Therapeutics Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Dyslipidemia Therapeutics Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Dyslipidemia Therapeutics Status and Prospect (2014-2024)
1.5 Global Market Size of Dyslipidemia Therapeutics (2014-2024)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Dyslipidemia Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Dyslipidemia Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.2 Sanofi
2.2.1 Business Overview
2.2.2 Dyslipidemia Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sanofi Dyslipidemia Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.3 Amgen
2.3.1 Business Overview
2.3.2 Dyslipidemia Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Amgen Dyslipidemia Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.4 Merck
2.4.1 Business Overview
2.4.2 Dyslipidemia Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck Dyslipidemia Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.5 Novartis
2.5.1 Business Overview
2.5.2 Dyslipidemia Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Novartis Dyslipidemia Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.6 Abbott Laboratories
2.6.1 Business Overview
2.6.2 Dyslipidemia Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Abbott Laboratories Dyslipidemia Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.7 AstraZeneca
2.7.1 Business Overview
2.7.2 Dyslipidemia Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 AstraZeneca Dyslipidemia Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.8 Mylan
2.8.1 Business Overview
2.8.2 Dyslipidemia Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Mylan Dyslipidemia Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.9 Kowa Pharmaceuticals
2.9.1 Business Overview
2.9.2 Dyslipidemia Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Kowa Pharmaceuticals Dyslipidemia Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.10 Novelion Therapeutics
2.10.1 Business Overview
2.10.2 Dyslipidemia Therapeutics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Novelion Therapeutics Dyslipidemia Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
3 Global Dyslipidemia Therapeutics Market Competition, by Players
3.1 Global Dyslipidemia Therapeutics Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Dyslipidemia Therapeutics Players Market Share
3.2.2 Top 10 Dyslipidemia Therapeutics Players Market Share
3.3 Market Competition Trend
4 Global Dyslipidemia Therapeutics Market Size by Regions
4.1 Global Dyslipidemia Therapeutics Revenue and Market Share by Regions
4.2 North America Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
4.3 Europe Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
4.5 South America Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
5 North America Dyslipidemia Therapeutics Revenue by Countries
5.1 North America Dyslipidemia Therapeutics Revenue by Countries (2014-2019)
5.2 USA Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
5.3 Canada Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
5.4 Mexico Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
6 Europe Dyslipidemia Therapeutics Revenue by Countries
6.1 Europe Dyslipidemia Therapeutics Revenue by Countries (2014-2019)
6.2 Germany Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
6.3 UK Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
6.4 France Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
6.5 Russia Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
6.6 Italy Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Dyslipidemia Therapeutics Revenue by Countries
7.1 Asia-Pacific Dyslipidemia Therapeutics Revenue by Countries (2014-2019)
7.2 China Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
7.3 Japan Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
7.4 Korea Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
7.5 India Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
8 South America Dyslipidemia Therapeutics Revenue by Countries
8.1 South America Dyslipidemia Therapeutics Revenue by Countries (2014-2019)
8.2 Brazil Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
8.3 Argentina Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
8.4 Colombia Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Dyslipidemia Therapeutics by Countries
9.1 Middle East and Africa Dyslipidemia Therapeutics Revenue by Countries (2014-2019)
9.2 Saudi Arabia Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
9.3 UAE Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
9.4 Egypt Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
9.5 Nigeria Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
9.6 South Africa Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
10 Global Dyslipidemia Therapeutics Market Segment by Type
10.1 Global Dyslipidemia Therapeutics Revenue and Market Share by Type (2014-2019)
10.2 Global Dyslipidemia Therapeutics Market Forecast by Type (2019-2024)
10.3 Statins Revenue Growth Rate (2014-2024)
10.4 Non-Statins Revenue Growth Rate (2014-2024)
10.5 Combinations Drugs Revenue Growth Rate (2014-2024)
11 Global Dyslipidemia Therapeutics Market Segment by Application
11.1 Global Dyslipidemia Therapeutics Revenue Market Share by Application (2014-2019)
11.2 Dyslipidemia Therapeutics Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2014-2019)
11.4 Retail Pharmacies Revenue Growth (2014-2019)
11.5 Online Pharmacies Revenue Growth (2014-2019)
12 Global Dyslipidemia Therapeutics Market Size Forecast (2019-2024)
12.1 Global Dyslipidemia Therapeutics Market Size Forecast (2019-2024)
12.2 Global Dyslipidemia Therapeutics Market Forecast by Regions (2019-2024)
12.3 North America Dyslipidemia Therapeutics Revenue Market Forecast (2019-2024)
12.4 Europe Dyslipidemia Therapeutics Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Dyslipidemia Therapeutics Revenue Market Forecast (2019-2024)
12.6 South America Dyslipidemia Therapeutics Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Dyslipidemia Therapeutics Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Dyslipidemia Therapeutics Picture
Table Product Specifications of Dyslipidemia Therapeutics
Table Global Dyslipidemia Therapeutics and Revenue (Million USD) Market Split by Product Type
Figure Global Dyslipidemia Therapeutics Revenue Market Share by Types in 2018
Figure Statins Picture
Figure Non-Statins Picture
Figure Combinations Drugs Picture
Table Global Dyslipidemia Therapeutics Revenue (Million USD) by Application (2014-2024)
Figure Dyslipidemia Therapeutics Revenue Market Share by Applications in 2018
Figure Hospital Pharmacies Picture
Figure Retail Pharmacies Picture
Figure Online Pharmacies Picture
Table Global Market Dyslipidemia Therapeutics Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Dyslipidemia Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Dyslipidemia Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Dyslipidemia Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Dyslipidemia Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Dyslipidemia Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Dyslipidemia Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Dyslipidemia Therapeutics Type and Applications
Table Pfizer Dyslipidemia Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Dyslipidemia Therapeutics Type and Applications
Table Sanofi Dyslipidemia Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Dyslipidemia Therapeutics Type and Applications
Table Amgen Dyslipidemia Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Dyslipidemia Therapeutics Type and Applications
Table Merck Dyslipidemia Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Dyslipidemia Therapeutics Type and Applications
Table Novartis Dyslipidemia Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories Dyslipidemia Therapeutics Type and Applications
Table Abbott Laboratories Dyslipidemia Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Dyslipidemia Therapeutics Type and Applications
Table AstraZeneca Dyslipidemia Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Dyslipidemia Therapeutics Type and Applications
Table Mylan Dyslipidemia Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Kowa Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Kowa Pharmaceuticals Dyslipidemia Therapeutics Type and Applications
Table Kowa Pharmaceuticals Dyslipidemia Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Novelion Therapeutics Basic Information, Manufacturing Base and Competitors
Table Novelion Therapeutics Dyslipidemia Therapeutics Type and Applications
Table Novelion Therapeutics Dyslipidemia Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Global Dyslipidemia Therapeutics Revenue (Million USD) by Players (2014-2019)
Table Global Dyslipidemia Therapeutics Revenue Share by Players (2014-2019)
Figure Global Dyslipidemia Therapeutics Revenue Share by Players in 2017
Figure Global Dyslipidemia Therapeutics Revenue Share by Players in 2018
Figure Global Top 5 Players Dyslipidemia Therapeutics Revenue Market Share in 2018
Figure Global Top 10 Players Dyslipidemia Therapeutics Revenue Market Share in 2018
Figure Global Dyslipidemia Therapeutics Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Dyslipidemia Therapeutics Revenue (Million USD) by Regions (2014-2019)
Table Global Dyslipidemia Therapeutics Revenue Market Share by Regions (2014-2019)
Figure Global Dyslipidemia Therapeutics Revenue Market Share by Regions (2014-2019)
Figure Global Dyslipidemia Therapeutics Revenue Market Share by Regions in 2018
Figure North America Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
Figure Europe Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
Figure South America Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
Table North America Dyslipidemia Therapeutics Revenue by Countries (2014-2019)
Table North America Dyslipidemia Therapeutics Revenue Market Share by Countries (2014-2019)
Figure North America Dyslipidemia Therapeutics Revenue Market Share by Countries (2014-2019)
Figure North America Dyslipidemia Therapeutics Revenue Market Share by Countries in 2018
Figure USA Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
Figure Canada Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
Figure Mexico Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
Table Europe Dyslipidemia Therapeutics Revenue (Million USD) by Countries (2014-2019)
Figure Europe Dyslipidemia Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Europe Dyslipidemia Therapeutics Revenue Market Share by Countries in 2018
Figure Germany Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
Figure UK Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
Figure France Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
Figure Russia Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
Figure Italy Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Dyslipidemia Therapeutics Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Dyslipidemia Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Dyslipidemia Therapeutics Revenue Market Share by Countries in 2018
Figure China Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
Figure Japan Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
Figure Korea Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
Figure India Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
Table South America Dyslipidemia Therapeutics Revenue by Countries (2014-2019)
Table South America Dyslipidemia Therapeutics Revenue Market Share by Countries (2014-2019)
Figure South America Dyslipidemia Therapeutics Revenue Market Share by Countries (2014-2019)
Figure South America Dyslipidemia Therapeutics Revenue Market Share by Countries in 2018
Figure Brazil Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
Figure Argentina Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
Figure Colombia Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Dyslipidemia Therapeutics Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Dyslipidemia Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Dyslipidemia Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Dyslipidemia Therapeutics Revenue Market Share by Countries in 2018
Figure Saudi Arabia Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
Figure UAE Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
Figure Egypt Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
Figure Nigeria Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
Figure South Africa Dyslipidemia Therapeutics Revenue and Growth Rate (2014-2019)
Table Global Dyslipidemia Therapeutics Revenue (Million USD) by Type (2014-2019)
Table Global Dyslipidemia Therapeutics Revenue Share by Type (2014-2019)
Figure Global Dyslipidemia Therapeutics Revenue Share by Type (2014-2019)
Figure Global Dyslipidemia Therapeutics Revenue Share by Type in 2019
Table Global Dyslipidemia Therapeutics Revenue Forecast by Type (2019-2024)
Figure Global Dyslipidemia Therapeutics Market Share Forecast by Type (2019-2024)
Figure Global Statins Revenue Growth Rate (2014-2019)
Figure Global Non-Statins Revenue Growth Rate (2014-2019)
Figure Global Combinations Drugs Revenue Growth Rate (2014-2019)
Table Global Dyslipidemia Therapeutics Revenue by Application (2014-2019)
Table Global Dyslipidemia Therapeutics Revenue Share by Application (2014-2019)
Figure Global Dyslipidemia Therapeutics Revenue Share by Application (2014-2019)
Figure Global Dyslipidemia Therapeutics Revenue Share by Application in 2019
Table Global Dyslipidemia Therapeutics Revenue Forecast by Application (2019-2024)
Figure Global Dyslipidemia Therapeutics Market Share Forecast by Application (2019-2024)
Figure Global Hospital Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Retail Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Online Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Dyslipidemia Therapeutics Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Dyslipidemia Therapeutics Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Dyslipidemia Therapeutics Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Dyslipidemia Therapeutics Revenue Market Forecast (2019-2024)
Figure Europe Dyslipidemia Therapeutics Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Dyslipidemia Therapeutics Revenue Market Forecast (2019-2024)
Figure South America Dyslipidemia Therapeutics Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Dyslipidemia Therapeutics Revenue Market Forecast (2019-2024)


【掲載企業】

Pfizer、Sanofi、Amgen、Merck、Novartis、Abbott Laboratories、AstraZeneca、Mylan、Kowa Pharmaceuticals、Novelion Therapeutics、

★調査レポート[脂質異常症治療薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9101945)販売に関する免責事項を必ずご確認ください。
★調査レポート[脂質異常症治療薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • エキソソーム診断および治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102023 / GlobalInfoResearch / 2019年9月16日 / 本調査レポートは、エキソソーム診断および治療の世界市場について調べ、まとめました。種類別セグメントは、機器、試薬、ソフトウェア等、用途別セグメントは、診断、治療等に区分しました。エキソソーム診断および治療の世界市場概観、企業動向、企業別エキソソーム診断および治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・エキソソーム診断および治療の市場概観 ・エキソソーム診断および治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・エキソソーム診断および治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・エキソソーム診断および治療の世界市場規模 ・エキソソーム診断および治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・エキソソーム診断および治療のアメリカ市場規模推移 ・エキソソーム診断および治療のカナダ市場規模推移 ・エキソソーム診断および治療のメキシコ市場規模推移 ・エキソソーム診断および治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Exosomes play a key role in facilitating cell-to-cell communication in the cancer prognosis. It suppresses the immune function by inducing apoptosis of activated cytotoxic T cells, which enable tumor progression in the human body. Scope of the Report: The global Exosome Diagnostics and Therapeutics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America,...
  • 糖鎖生物学（診断と治療）の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102025 / GlobalInfoResearch / 2019年9月16日 / 本調査レポートは、糖鎖生物学（診断と治療）の世界市場について調べ、まとめました。種類別セグメントは、診断、治療学等、用途別セグメントは、クリニック、病院、その他等に区分しました。糖鎖生物学（診断と治療）の世界市場概観、企業動向、企業別糖鎖生物学（診断と治療）シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・糖鎖生物学（診断と治療）の市場概観 ・糖鎖生物学（診断と治療）の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・糖鎖生物学（診断と治療）の企業別販売動向、市場シェア、市場集中度、競争動向 ・糖鎖生物学（診断と治療）の世界市場規模 ・糖鎖生物学（診断と治療）の北米市場分析（アメリカ、カナダ、メキシコ等） ・糖鎖生物学（診断と治療）のアメリカ市場規模推移 ・糖鎖生物学（診断と治療）のカナダ市場規模推移 ・糖鎖生物学（診断と治療）のメキシコ市場規模推移 ・糖鎖生物学（診断と治療）のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Glycobiology is the study of the structure, biosynthesis, and biology of saccharides that are widely distributed in nature. Glycobiology is the study of the structure, function and biology of carbohydrates, also called glycans. Glycans are present in every living organism. Glycobiology is a rapidly growing field in biology, with relevance to biomedicine, biotechnology and basic research. Scope of the Report: Glycans are diverse, complex molecules and their functions are determined by their unique structures. Effective enzymatic tools and analytical techniques are required to properly elucidate glycan structure, which can then be correlated to a specific function. Glycosylation defines the adhesive...
  • mRNAワクチンおよび治療薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9100023 / GlobalInfoResearch / 2019年10月9日 / 本調査レポートは、mRNAワクチンおよび治療薬の世界市場について調べ、まとめました。種類別セグメントは、感染症、がん、その他等、用途別セグメントは、病院、研究機関等に区分しました。mRNAワクチンおよび治療薬の世界市場概観、企業動向、企業別mRNAワクチンおよび治療薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・mRNAワクチンおよび治療薬の市場概観 ・mRNAワクチンおよび治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・mRNAワクチンおよび治療薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・mRNAワクチンおよび治療薬の世界市場規模 ・mRNAワクチンおよび治療薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・mRNAワクチンおよび治療薬のアメリカ市場規模推移 ・mRNAワクチンおよび治療薬のカナダ市場規模推移 ・mRNAワクチンおよび治療薬のメキシコ市場規模推移 ・mRNAワクチンおよび治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The global mRNA Vaccine And Therapeutics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of mRNA Vaccine And Therapeutics. Europe also play important...
  • 薬物乱用治療薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103563 / GlobalInfoResearch / 2019年9月27日 / 本調査レポートは、薬物乱用治療薬の世界市場について調べ、まとめました。種類別セグメントは、オピオイド中毒、タバコ/ニコチン中毒、アルコール依存症等、用途別セグメントは、病院＆クリニック、住宅（病院以外）等に区分しました。薬物乱用治療薬の世界市場概観、企業動向、企業別薬物乱用治療薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・薬物乱用治療薬の市場概観 ・薬物乱用治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・薬物乱用治療薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・薬物乱用治療薬の世界市場規模 ・薬物乱用治療薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・薬物乱用治療薬のアメリカ市場規模推移 ・薬物乱用治療薬のカナダ市場規模推移 ・薬物乱用治療薬のメキシコ市場規模推移 ・薬物乱用治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Substance Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of substance abuse. Some commonly used drug for treatment of substance abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine. Scope of the Report: The global Substance Abuse Therapeutics market is valued at xx million USD in 2018 and is expected to reach xx million USD...
  • 季節性情動障害治療薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101311 / GlobalInfoResearch / 2019年9月10日 / 本調査レポートは、季節性情動障害治療薬の世界市場について調べ、まとめました。種類別セグメントは、光療法（光線療法）、薬物療法、その他等、用途別セグメントは、病院、診療所、その他等に区分しました。季節性情動障害治療薬の世界市場概観、企業動向、企業別季節性情動障害治療薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・季節性情動障害治療薬の市場概観 ・季節性情動障害治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・季節性情動障害治療薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・季節性情動障害治療薬の世界市場規模 ・季節性情動障害治療薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・季節性情動障害治療薬のアメリカ市場規模推移 ・季節性情動障害治療薬のカナダ市場規模推移 ・季節性情動障害治療薬のメキシコ市場規模推移 ・季節性情動障害治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Seasonal affective disorder (SAD) is a mood disorder subset in which people who have normal mental health throughout most of the year exhibit depressive symptoms at the same time each year, most commonly in the winter. Common symptoms include sleeping too much, having little to no energy, and overeating. The condition in the summer can include heightened anxiety. Scope of the Report: The global Seasonal Affective Disorder Therapeutics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024....
  • 核酸ベース遺伝子治療薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102917 / GlobalInfoResearch / 2019年9月23日 / 本調査レポートは、核酸ベース遺伝子治療薬の世界市場について調べ、まとめました。種類別セグメントは、DNA、RNA等、用途別セグメントは、学術および政府研究所、製薬およびバイオテクノロジー企業、受託研究機関、病院および診断センター、その他等に区分しました。核酸ベース遺伝子治療薬の世界市場概観、企業動向、企業別核酸ベース遺伝子治療薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・核酸ベース遺伝子治療薬の市場概観 ・核酸ベース遺伝子治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・核酸ベース遺伝子治療薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・核酸ベース遺伝子治療薬の世界市場規模 ・核酸ベース遺伝子治療薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・核酸ベース遺伝子治療薬のアメリカ市場規模推移 ・核酸ベース遺伝子治療薬のカナダ市場規模推移 ・核酸ベース遺伝子治療薬のメキシコ市場規模推移 ・核酸ベース遺伝子治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Nucleic acid-based molecules are utilized as research tools within the broad borders of gene therapy and the emerging field of molecular medicine. Scope of the Report: The global Nucleic-Acid Based Gene Therapeutics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot...
  • 結膜炎治療薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101958 / GlobalInfoResearch / 2019年9月16日 / 本調査レポートは、結膜炎治療薬の世界市場について調べ、まとめました。種類別セグメントは、アレルギー性結膜炎、細菌性結膜炎、ウイルス性結膜炎等、用途別セグメントは、病院、外来等に区分しました。結膜炎治療薬の世界市場概観、メーカー動向、メーカー別結膜炎治療薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・結膜炎治療薬の市場概観 ・結膜炎治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・結膜炎治療薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・結膜炎治療薬の世界市場規模 ・結膜炎治療薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・結膜炎治療薬のアメリカ市場規模推移 ・結膜炎治療薬のカナダ市場規模推移 ・結膜炎治療薬のメキシコ市場規模推移 ・結膜炎治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Conjunctivitis is an inflammation or swelling of the conjunctiva. Scope of the Report: The worldwide market for Conjunctivitis Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Conjunctivitis Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Akorn, Incorporated ALLERGAN...

    • ◆H&Iグローバルリサーチのお客様（例）◆